Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mesenchymal Stem Cell-Derived Extracellular Vesicles Alone or in Conjunction With a Sdkp-Conjugated Self-Assembling Peptide Improve a Rat Model of Myocardial Infarction Publisher Pubmed



Firoozi S1, 2 ; Pahlavan S3 ; Ghanian MH2 ; Rabbani S4 ; Barekat M5 ; Nazari A3 ; Pakzad M3 ; Shekari F3, 7 ; Hassani SN3 ; Moslem F3 ; Lahrood FN3 ; Soleimani M6 ; Baharvand H3, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  3. 3. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  4. 4. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  6. 6. Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Developmental Biology, University of Science and Culture, Tehran, Iran

Source: Biochemical and Biophysical Research Communications Published:2020


Abstract

Purpose: The aim of this study was to investigate the cardiac repair effect of human bone marrow mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) after intramyocardial injection in free form or encapsulated within a self-assembling peptide hydrogel modified with SDKP motif, in a rat model of myocardial infarction (MI). Methods: MSC-EVs were isolated by ultracentrifuge and characterized for physical parameters and surface proteins. Furthermore, cellular uptake and cardioprotective effects of MSC-EVs were evaluated in vitro using neonatal mouse cardiomyocytes (NMCMs). In vivo effects of MSC-EVs on cardiac repair were studied in rat MI model by comparing the vehicle group (injected with PBS), EV group (injected with MSC-EVs) and Gel + EV group (injected with MSC-EVs encapsulated in (RADA)4-SDKP hydrogel) with respect to cardiac function and fibrotic area using echocardiography and Masson's trichrome staining, respectively. Histological sections were assessed by α-SMA and CD68 immunostaining to investigate the angiogenic and anti-inflammatory effects of the MSC-EVs. Results: We observed the uptake of MSC-EVs into NMCMs which led to NMCMs protection against H2O2-induced oxidative stress by substantial reduction of apoptosis. In myocardial infarcted rats, cardiac function was improved after myocardial injection of MSC-EVs alone or in conjunction with (RADA)4-SDKP hydrogel. This functional restoration coincided with promotion of angiogenesis and decrement of fibrosis and inflammation. Conclusion: These data demonstrated that MSC-EVs can be used alone as a potent therapeutic agent for improvement of myocardial infarction. © 2020 Elsevier Inc.
Other Related Docs
23. Cell Type-Specific Extracellular Vesicles and Their Impact on Health and Disease, International Journal of Molecular Sciences (2024)
26. Novel Cell-Based Therapies in Hepatic Disorders, Journal of Mazandaran University of Medical Sciences (2020)
36. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
49. Exosomal Micrornas in Regulation of Tumor Cells Resistance to Apoptosis, Biochemistry and Biophysics Reports (2024)